1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 37
2.5 Porters Fiver Forces Analysis 41
3 Segmentation of Asia Pacific Market by System Component 45
3.1 Market Overview by System Component 45
3.2 Data Collection Tools 47
3.2.1 Digital Platforms 49
3.2.2 Mobile Apps 50
3.2.3 Desktop-based Software 51
3.2.4 Wearables 52
3.2.5 Biosensors 53
3.3 Data Integration Systems 54
4 Segmentation of Asia Pacific Market by Therapeutic Area 55
4.1 Market Overview by Therapeutic Area 55
4.2 Cardiovascular Diseases 57
4.3 Neurodegenerative Disorders 58
4.3.1 Parkinsons Disease 60
4.3.2 Multiple Sclerosis 61
4.3.3 Alzheimers Disease 62
4.4 Sleep and Movement Diseases 63
4.5 Psychiatric Disorders 64
4.6 Chronic Pain 65
4.7 Gastrointestinal Diseases 66
4.8 Diabetes 67
4.9 Respiratory Conditions 68
4.10 Other Diseases 69
5 Segmentation of Asia Pacific Market by Application 70
5.1 Market Overview by Application 70
5.2 Wellness 72
5.3 Disease Diagnosis 73
5.4 Personalised Medication 74
5.5 Drug Discovery and Development 75
6 Segmentation of Asia Pacific Market by Development Status 77
6.1 Market Overview by Development Status 77
6.2 Novel Digital Biomarkers 80
6.3 Original Digital Biomarkers 81
6.4 Approved Digital Biomarkers 82
7 Segmentation of Asia Pacific Market by End User 83
7.1 Market Overview by End User 83
7.2 Biopharmaceutical Companies & Labs 85
7.3 Healthcare Providers 86
7.4 Insurance Payers 87
8 Asia-Pacific Market 2019-2030 by Country 88
8.1 Overview of Asia-Pacific Market 88
8.2 Japan 91
8.3 China 94
8.4 Australia 96
8.5 India 98
8.6 South Korea 100
8.7 Rest of APAC Region 102
9 Competitive Landscape 104
9.1 Overview of Key Vendors 104
9.2 New Product Launch, Partnership, Investment, and M&A 107
9.3 Company Profiles 108
Actigraph LLC 108
Akili Interactive Labs 110
AliveCor Inc 111
Altoida Inc 112
Amgen Inc 113
Bayer AG 114
Biogen Inc 115
Cambridge Cognition Plc 116
Eli Lilly and Company 117
Evidation Health, Inc. 118
F. Hoffmann-La Roche Ltd 119
Fitbit Inc 120
GlaxoSmithKline Plc 121
Happify Health 122
Human API 123
IXICO Plc 124
Koninklijke Philips N.V. 125
Medical Care Corporation 126
Medopad Ltd 127
Mindstrong Health 128
Neurotrack Technology, Inc 129
Novartis International AG 130
Pfizer Inc. 131
Quanterix Corporation 132
Sanofi S.A. 133
The Takeda Pharmaceuticals Company Limited 134
Verily Life Sciences 135
Winterlight Labs Inc. 136
10 Investing in Asia Pacific Market: Risk Assessment and Management 137
10.1 Risk Evaluation of Asia Pacific Market 137
10.2 Critical Success Factors (CSFs) 140
Related Reports and Products 143